Management of pregnancy complicated by central core disease

Niki, A.; Ochiai, Daigo; Iwai, Miwako; Sato, Yoko; Yoshino, Kurt; Yamada, Teiichi

doi:10.1016/j.ijoa.2020.05.004

Cited by 2 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…General anaesthesia typically utilises intravenous induction and volatile maintenance, but the use of total intravenous anaesthesia (TIVA) has rapidly increased over the past decade in the United Kingdom (from 8% to 26% of all GAs) [ 3 ]. The extent to which this translates to obstetric practice is unclear: case reports and single‐centre case series describing TIVA for obstetric anaesthesia have been published [ 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 ], but no systemwide evaluation has been conducted, and the impact of TIVA on maternal and neonatal outcomes remains unknown [ 15 ]. We designed a multicentre service evaluation to describe the incidence and practice of TIVA for obstetric surgery and immediate maternal and neonatal recovery outcomes, in participating centres in the United Kingdom.…”

Section: Introductionmentioning

confidence: 99%

“…General anaesthesia typically utilises intravenous induction and volatile maintenance, but the use of total intravenous anaesthesia (TIVA) has rapidly increased over the past decade in the United Kingdom (from 8% to 26% of all GAs) [3]. The extent to which this translates to obstetric practice is unclear: case reports and single-centre case series describing TIVA for obstetric anaesthesia have been published [4][5][6][7][8][9][10][11][12][13][14], but no systemwide evaluation has been conducted, and the impact of TIVA on maternal and neonatal outcomes remains unknown [15].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

ObsTIVA‐UK: a service evaluation of obstetric total intravenous anaesthesia in the United Kingdom

Metodiev,

Iliff,

Sharif

et al. 2024

Anaesthesia Reports

View full text Add to dashboard Cite

SummaryWe conducted a prospective observational service evaluation across the United Kingdom on the use of total intravenous anaesthesia (TIVA) for obstetric surgery between November 2022 and June 2023. The primary aim was to describe the incidence of TIVA for obstetric surgery within participating units, with secondary aims to describe maternal and neonatal postoperative recovery indicators. Of 184 maternity units in the United Kingdom, 30 (16%) contributed data to the service evaluation. There were 104 patients who underwent caesarean delivery under TIVA and 19 patients had TIVA for other reasons. Infusions of propofol and remifentanil were used in 100% and 84% of cases, respectively. Fifty‐nine out of 103 live neonates (57%) required some form of respiratory support. Of the neonates with recorded data, 73% and 17% had Apgar scores < 7 at 1 and 5 min respectively. No neonates were recorded to have Apgar scores < 7 at 10 min. Further prospective research is required to investigate the impact of obstetric TIVA on maternal and neonatal outcomes and inform best practice recommendations.

show abstract

Section: Introductionmentioning

confidence: 99%

“…General anaesthesia typically utilises intravenous induction and volatile maintenance, but the use of total intravenous anaesthesia (TIVA) has rapidly increased over the past decade in the United Kingdom (from 8% to 26% of all GAs) [3]. The extent to which this translates to obstetric practice is unclear: case reports and single-centre case series describing TIVA for obstetric anaesthesia have been published [4][5][6][7][8][9][10][11][12][13][14], but no systemwide evaluation has been conducted, and the impact of TIVA on maternal and neonatal outcomes remains unknown [15].…”

Section: Introductionmentioning

confidence: 99%